Hedge Fund Wagers Million on Biotech After FDA Milestone
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
Conduct a value comparison of no annual fee cash back cards to find the right one for your spending needs. Make informed choices.
25,387 articlesA major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
Stocks ride to record highs while bond yields climb. This article explains why treasury yields soaring that's driving...
Bloom Energy has drawn big investor attention after a dramatic rally. This guide breaks down what the company does, w...
Palantir has surprised and divided investors with big moves and bold AI promises. This guide explains what to watch, ...
RxSight's Q4 2025 earnings report could set the tone for its 2026 trajectory. This guide breaks down the key numbers,...
Intel stock has moved faster than its turnaround plan in many eyes. As Lip-Bu Tan reshapes the company, investors mus...
As AI accelerates, the question for investors is clear: will Verisk's valuable data keep its edge or fade into a sea ...
A hypothetical SpaceX IPO could ride a powerful tailwind if a Google cloud deal brings $30 billion in AI compute reve...
delek holdings rallied today captured market attention as a mid-cap refiner with jet-fuel exposure and a strategic st...
Nvidia dominates AI GPUs, but Broadcom could offer a different path into AI growth. This article lays out three concr...
A high-growth, small-cap name has tumbled after a rough period. This guide breaks down whether the dip creates a real...
As AI reshapes markets, Palantir’s unique software moat could ignite a new chapter in growth. This guide compares Pal...